Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis

Published:2017-01-02 Issue:7 Volume:37 Page:974-981
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Li Tao¹,Qu Yundong¹,Guo Ying²,Wang Yan¹,Wang Lei¹

Affiliation:

1. Department of Infectious Diseases and Hepatology; The Second Hospital of Shandong University; Jinan China

2. Department of Intensive Care Unit; The Second Hospital of Shandong University; Jinan China

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13336/fullpdf

Reference23 articles.

1. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?;Fabrizi;J Viral Hepat,2012

2. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy;Nakayama;J Am Soc Nephrol,2000

3. Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of hepatitis C in patients with end stage renal disease;Bhamidimarri;J Hepatol,2015

4. Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/min;Nazario;Liver Int,2016

5. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study;Roth;Lancet,2015

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for dialysis patients with hepatitis C virus (HCV) infection;Cochrane Database of Systematic Reviews;2023-04-25

2. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr;Pharmaceuticals;2023-03-25

3. Tratamiento de la infección del virus de la hepatitis C: de la terapia con interferón a los antivirales de acción directa;Iatreia;2022-08-18

4. Breakthroughs in hepatitis C research: from discovery to cure;Nature Reviews Gastroenterology & Hepatology;2022-05-20

5. Revolution in the diagnosis and management of hepatitis C virus infection in current era;World Journal of Hepatology;2022-04-27